Logo image of CTEK.CA

CLEANTEK INDUSTRIES INC (CTEK.CA) Stock Fundamental Analysis

TSX-V:CTEK - TSX Venture Exchange - CA75101V1013 - Common Stock - Currency: CAD

0.5  -0.01 (-1.96%)

Fundamental Rating

2

Overall CTEK gets a fundamental rating of 2 out of 10. We evaluated CTEK against 28 industry peers in the Energy Equipment & Services industry. CTEK may be in some trouble as it scores bad on both profitability and health. CTEK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CTEK has reported negative net income.
In the past 5 years CTEK always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: CTEK reported negative operating cash flow in multiple years.
CTEK.CA Yearly Net Income VS EBIT VS OCF VS FCFCTEK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M -6M -8M

1.2 Ratios

CTEK's Return On Assets of -10.63% is on the low side compared to the rest of the industry. CTEK is outperformed by 85.71% of its industry peers.
Looking at the Return On Equity, with a value of -36.55%, CTEK is doing worse than 85.71% of the companies in the same industry.
With a Return On Invested Capital value of 1.11%, CTEK is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -10.63%
ROE -36.55%
ROIC 1.11%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CTEK.CA Yearly ROA, ROE, ROICCTEK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K

1.3 Margins

The Operating Margin of CTEK (1.42%) is worse than 75.00% of its industry peers.
CTEK has a better Gross Margin (59.94%) than 100.00% of its industry peers.
CTEK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.42%
PM (TTM) N/A
GM 59.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.51%
GM growth 5Y19.11%
CTEK.CA Yearly Profit, Operating, Gross MarginsCTEK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CTEK is destroying value.
There is no outstanding debt for CTEK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CTEK.CA Yearly Shares OutstandingCTEK.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
CTEK.CA Yearly Total Debt VS Total AssetsCTEK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M

2.2 Solvency

CTEK has an Altman-Z score of -3.79. This is a bad value and indicates that CTEK is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -3.79, CTEK is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
CTEK has a Debt/Equity ratio of 1.59. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.59, CTEK is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Altman-Z -3.79
ROIC/WACC0.14
WACC7.93%
CTEK.CA Yearly LT Debt VS Equity VS FCFCTEK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M

2.3 Liquidity

CTEK has a Current Ratio of 1.13. This is a normal value and indicates that CTEK is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CTEK (1.13) is worse than 89.29% of its industry peers.
CTEK has a Quick Ratio of 1.13. This is a normal value and indicates that CTEK is financially healthy and should not expect problems in meeting its short term obligations.
CTEK has a worse Quick ratio (1.13) than 60.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
CTEK.CA Yearly Current Assets VS Current LiabilitesCTEK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 1M 2M 3M 4M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.23% over the past year.
CTEK shows a small growth in Revenue. In the last year, the Revenue has grown by 6.66%.
CTEK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 107.92% yearly.
EPS 1Y (TTM)49.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)6.66%
Revenue growth 3Y184.11%
Revenue growth 5Y107.92%
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y233.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTEK.CA Yearly Revenue VS EstimatesCTEK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CTEK.CA Yearly EPS VS EstimatesCTEK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -0.05 -0.1 -0.15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CTEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 12.38 indicates a correct valuation of CTEK.
CTEK's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, CTEK is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 12.38
CTEK.CA Price Earnings VS Forward Price EarningsCTEK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTEK is valued a bit more expensive than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.09
CTEK.CA Per share dataCTEK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

CTEK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CTEK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEANTEK INDUSTRIES INC

TSX-V:CTEK (3/7/2025, 7:00:00 PM)

0.5

-0.01 (-1.96%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)04-26 2024-04-26/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.71%
Ins Owner ChangeN/A
Market Cap14.63M
Analysts80
Price Target1.1 (120%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.38
P/S 1.05
P/FCF N/A
P/OCF N/A
P/B 2.93
P/tB 3.23
EV/EBITDA 9.09
EPS(TTM)-0.07
EYN/A
EPS(NY)0.04
Fwd EY8.08%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.48
BVpS0.17
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.63%
ROE -36.55%
ROCE 1.54%
ROIC 1.11%
ROICexc 1.3%
ROICexgc 1.35%
OM 1.42%
PM (TTM) N/A
GM 59.94%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.51%
GM growth 5Y19.11%
F-ScoreN/A
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Debt/EBITDA 3.26
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z -3.79
F-ScoreN/A
WACC7.93%
ROIC/WACC0.14
Cap/Depr(3y)53.84%
Cap/Depr(5y)37.9%
Cap/Sales(3y)11.96%
Cap/Sales(5y)8.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y233.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.66%
Revenue growth 3Y184.11%
Revenue growth 5Y107.92%
Sales Q2Q%N/A
Revenue Next Year11.15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y106.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year115.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y199.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y432.05%
OCF growth 3YN/A
OCF growth 5YN/A